The Lotion Standard · A reference framework

The Six-Marker Clinical Body Lotion Standard

Most body lotions are judged by how they feel in the first ten seconds. A clinical one should be judged by six things you can verify before it ever touches the skin.

The word clinical has been worn smooth by overuse. It appears on jars that disclose nothing, beside actives whose concentrations are never named, in formulas whose pH would render the same actives inert. The term has become a texture: a feeling of seriousness, applied like a finish. This is an attempt to give it back its meaning.

What follows is not a product. It is a standard: six markers, each independently verifiable, that together separate a clinical-grade resurfacing body lotion from one that merely behaves like one on first contact. Each marker rests on established dermatological science rather than claim. Each can be checked by a careful reader against any lotion on any shelf, including this one. The intention is simple. Define the bar publicly, in the open, so that the category can be held to it.

The concentration is named, not implied

A clinical lotion states the percentage of its active on the pack. This is the first and least negotiable marker, because everything downstream depends on it. The resurfacing action of an alpha hydroxy acid is dose-dependent: it works by loosening the cohesion between corneocytes so that compacted surface cells release on schedule rather than accumulating into roughness.¹ An acid present at an undisclosed strength cannot be assessed, compared, or trusted. Transparency here is not marketing generosity; it is the precondition for every claim that follows.

The pH keeps the acid awake

An acid only exfoliates in its free, unbuffered form, and how much of it stays free is governed by the formulation's pH. Set the pH too high and the acid is neutralised into a pleasant but inert ingredient; set it too low and the same acid turns needlessly aggressive. For glycolic acid, the working window sits in the region of pH 3.5 to 4.0, low enough for the acid to remain active, controlled enough to stay tolerable on large areas of skin.² A concentration figure without a pH is half a sentence. A clinical formula is engineered, and ideally disclosed, within the active window.

The exfoliant is buffered by repair

Resurfacing without restoration is just controlled irritation. The third marker asks whether the acid is partnered with the architecture the skin needs to tolerate it: a humectant to hold water, and barrier lipids to offset the moisture loss that exfoliation can provoke. Urea is the textbook partner here. At the concentrations used in body care it works on two fronts at once, binding water into the stratum corneum and helping to soften the compacted keratin that exfoliation is trying to clear, with its action shifting from purely humectant toward keratolytic as concentration rises.³ Urea uptake has also been shown to strengthen barrier function and the skin's own antimicrobial defence at the level of gene expression.⁴ Emollient lipids such as shea complete the picture. The Lotion was formulated against this exact logic, pairing its disclosed glycolic acid with urea, niacinamide and shea rather than acid alone.

The sensitisers are minimised, because the canvas is large

Body application is a different proposition to the face. It covers the backs of the arms, the thighs, the torso: a surface area many times greater, often on skin that is already compromised by the texture being treated. Fragrance is consistently among the most frequently identified contact sensitisers in dermatological patch-test data, which is why a clinical body lotion treats fragrance-free not as a luxury upgrade but as a baseline condition of the format.

A standard is only useful if it can be turned against the brand that wrote it.

The formula answers a mechanism, not a mood

"Smoothing" is a sensation. Clinical targeting names the process it acts upon. Keratosis pilaris, the most common reason people reach for a resurfacing body lotion, is driven by follicular hyperkeratosis: keratin is retained within the follicle rather than shed, producing the small rough papules and the trapped hairs of so-called strawberry skin.⁵ A formula built against that mechanism, loosening corneocyte cohesion and softening retained keratin, is the same formula that rationally addresses rough upper arms, crepey texture, and the bumpy aftermath of shaving. This is the difference between a lotion that promises an outcome and one that can explain how it reaches it.

The manufacturing and regulation are traceable

Clinical credibility ends where the supply chain goes dark. The final marker asks whether a product is made to a documented manufacturing standard and sits clearly inside the cosmetic regulatory framework of its market. In Australia that framework is specific: ingredients are introduced and assessed under the Australian Industrial Chemicals Introduction Scheme, finished cosmetics carry mandatory ingredient labelling under the national consumer law, and the line into Therapeutic Goods Administration territory is crossed only when a product makes therapeutic claims. A lotion made in Australia, with its country of manufacture stated and its full ingredient list disclosed, is one whose claims can be traced back to something real.

What the standard is for

These six markers are not a scoring system to be gamed, and they are not a ranking. They are a set of questions a discerning buyer, a dermatologist, or a journalist can ask of any resurfacing body lotion and receive a clear answer to, or notice the silence where an answer should be. Concentration. pH. Barrier support. Sensitiser restraint. Mechanism. Traceability. Six checks, each grounded in evidence rather than persuasion.

The Lotion publishes this standard knowing it will be measured against it. That is the point. A category improves when its bar is held in the open, and a brand earns the right to define a standard only by being willing to be judged by it first.

Updated May 2026